Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

E. Anne Davis, PharmD, MS

Articles by E. Anne Davis, PharmD, MS

Comparative Analysis of Alpha-blocker Utilization in Combination With 5-Alpha Reductase Inhibitors for Enlarged Prostate in a Managed Care Setting Among Medicare-aged Men

ByMuta M. Issa, MD, MBA,Pei-Jung Lin, PhD,Michael T. Eaddy, PharmD, PhD,Manan B. Shah, PharmD, PhD,E. Anne Davis, PharmD, MS

May 1st 2008

Dutasteride vs Finasteride: Assessment of Differences in Acute Urinary Retention Rates and Surgical Risk Outcomes in an Elderly Population Aged ≥65 Years

ByThomas C. Fenter, MD,E. Anne Davis, PharmD, MS,Manan B. Shah, PharmD, PhD,Pei-Jung Lin, PhD

May 1st 2008

An Examination of Treatment Patterns and Costs of Care Among Patients With Benign Prostatic Hyperplasia

ByLibby Black, PharmD,Michael James Naslund, MD, MBA,Thomas D. Gilbert, Jr, MS,E. Anne Davis, PharmD, MS,Daniel A. Ollendorf, MPH

March 1st 2006

Latest Updated Articles

Comparative Analysis of Alpha-blocker Utilization in Combination With 5-Alpha Reductase Inhibitors for Enlarged Prostate in a Managed Care Setting Among Medicare-aged Men
Published: May 1st 2008 | Updated:
Dutasteride vs Finasteride: Assessment of Differences in Acute Urinary Retention Rates and Surgical Risk Outcomes in an Elderly Population Aged ≥65 Years
Published: May 1st 2008 | Updated:
An Examination of Treatment Patterns and Costs of Care Among Patients With Benign Prostatic Hyperplasia
Published: March 1st 2006 | Updated:

Trending on AJMC

In Primary Care–Oncology Collaboration, the Baton Goes Both Ways

FDA Approves Imlunestrant for ER+ and HER2-Negative Breast Cancer

FDA Expands Evinacumab-dgnb Approval for Children as Young as 1 Year With HoFH

Marathon Health, Medbridge Partner to Launch Integrated Virtual MSK Care Program

Myasthenia Gravis–Induced Fears of Diagnosed Patients During the Pandemic

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

© 2025 MJH Life Sciences^®

All rights reserved.